User profiles for B. Shinkins
Bethany ShinkinsUniversity of Warwick Verified email at warwick.ac.uk Cited by 2253 |
[HTML][HTML] At what times during infection is SARS-CoV-2 detectable and no longer detectable using RT-PCR-based tests? A systematic review of individual participant …
… b Time to undetectable virus in upper and lower respiratory tract samples in participants
who were tested with both upper and lower respiratory tract sampling. Kaplan-Meier with 95% …
who were tested with both upper and lower respiratory tract sampling. Kaplan-Meier with 95% …
Blood CEA levels for detecting recurrent colorectal cancer
BD Nicholson, B Shinkins, I Pathiraja… - Cochrane Database …, 2015 - cochranelibrary.com
Background Testing for carcino‐embryonic antigen (CEA) in the blood is a recommended part
of follow‐up to detect recurrence of colorectal cancer following primary curative treatment. …
of follow‐up to detect recurrence of colorectal cancer following primary curative treatment. …
What factors affect patients' ability to access healthcare? An overview of systematic reviews
…, C Renwick, T Ensor, B Shinkins… - Tropical Medicine & …, 2021 - Wiley Online Library
OBJECTIVES This overview aims to synthesise global evidence on factors affecting
healthcare access, and variations across low‐ and middle‐income countries (LMICs) vs. high‐…
healthcare access, and variations across low‐ and middle‐income countries (LMICs) vs. high‐…
Symptoms, unmet needs, psychological well‐being and health status in survivors of prostate cancer: implications for redesigning follow‐up
E Watson, B Shinkins, E Frith, D Neal… - BJU …, 2016 - Wiley Online Library
Objective To explore ongoing symptoms, unmet needs, psychological wellbeing, self‐efficacy
and overall health status in survivors of prostate cancer. Patients and Methods An …
and overall health status in survivors of prostate cancer. Patients and Methods An …
Diagnostic accuracy studies: how to report and analyse inconclusive test results
Failure to report inconclusive test results can lead to misleading conclusions regarding the
accuracy and clinical usefulness of a diagnostic tool. We show that these results are often …
accuracy and clinical usefulness of a diagnostic tool. We show that these results are often …
Gradual versus abrupt smoking cessation: a randomized, controlled noninferiority trial
Background: Most smoking cessation guidelines advise quitting abruptly. However, many
quit attempts involve gradual cessation. If gradual cessation is as successful, smokers can be …
quit attempts involve gradual cessation. If gradual cessation is as successful, smokers can be …
Sensitivity of chest X-ray for detecting lung cancer in people presenting with symptoms: a systematic review
…, A Grice, WT Hamilton, RR Lopez, B Shinkins… - British Journal of …, 2019 - bjgp.org
Background Despite increasing use of computed tomography (CT), chest X-ray remains the
first-line investigation for suspected lung cancer in primary care in the UK. No systematic …
first-line investigation for suspected lung cancer in primary care in the UK. No systematic …
Site and stage of colorectal cancer influence the likelihood and distribution of disease recurrence and postrecurrence survival: data from the FACS randomized …
SA Pugh, B Shinkins, A Fuller, J Mellor, D Mant… - Annals of …, 2016 - journals.lww.com
… 1A, B). When just those participants with recurrence from a Dukes’ C primary tumor are
considered, there is no difference in postrecurrence survival according to site of the original …
considered, there is no difference in postrecurrence survival according to site of the original …
[HTML][HTML] The diagnostic accuracy of a single CEA blood test in detecting colorectal cancer recurrence: Results from the FACS trial
Objective To evaluate the diagnostic accuracy of a single CEA (carcinoembryonic antigen)
blood test in detecting colorectal cancer recurrence. Background Patients who have …
blood test in detecting colorectal cancer recurrence. Background Patients who have …
[HTML][HTML] Should all acutely ill children in primary care be tested with point-of-care CRP: a cluster randomised trial
…, A De Sutter, B Aertgeerts, B Shinkins… - BMC medicine, 2016 - Springer
Background Point-of-care blood C-reactive protein (CRP) testing has diagnostic value in
helping clinicians rule out the possibility of serious infection. We investigated whether it should …
helping clinicians rule out the possibility of serious infection. We investigated whether it should …